The company plans to use the investment to complete clinical trials for their gene therapy products aimed at choroideremia, retinitis pigmentosa, and macular dystrophy.
{iframe}http://www.biospectrumindia.com/news/23/9214/uk-based-biotech-firm-raises-45-m.html{/iframe}